Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Shandong Pharmaceutical Glass Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 16.04%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
SHSE:600529's 3-Year ROIIC % is ranked better than 70.77% of 390
companies
in the Packaging & Containers industry
Industry Median: 1.56
vs SHSE:600529: 16.04
Shandong Pharmaceutical Glass Co (SHSE:600529) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Shandong Pharmaceutical Glass Co 3-Year ROIIC % Related Terms
Shandong Pharmaceutical Glass Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co 3-Year ROIIC % Chart
SHSE:600529 vs SW, PKG, IP: 3-Year ROIIC % Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co 3-Year ROIIC % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a 3-Year ROIIC % of 16.04 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 24% below median its historical median of 21.11. Over the past decade, Shandong Pharmaceutical Glass Co's 3-Year ROIIC % has ranged from 6.92 to 620.25. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #114 out of 390 companies in the Packaging & Containers industry, placing it in the top 29.2%.
Is Shandong Pharmaceutical Glass Co's 3-Year ROIIC % too high?
Shandong Pharmaceutical Glass Co's current 3-Year ROIIC % of 16.04 is 24% below median its 10-year median of 21.11. Over the past 10 years, this metric has ranged from a low of 6.92 to a high of 620.25. The Packaging & Containers industry median 3-Year ROIIC % is 1.56. Shandong Pharmaceutical Glass Co's value of 16.04 is 928.2% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #114 out of 390 companies in the Packaging & Containers industry, which is above the industry midpoint. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's 3-Year ROIIC % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #114 out of 390 companies for 3-Year ROIIC %. This puts Shandong Pharmaceutical Glass Co in the upper half of its industry. The industry median 3-Year ROIIC % is 1.56. Shandong Pharmaceutical Glass Co's value of 16.04 is 928.2% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own 3-Year ROIIC % has ranged from 6.92 to 620.25 over the past decade. While the company's 10-year median is 21.11 vs. the industry median of 1.56, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Packaging & Containers company?
The median 3-Year ROIIC % among Packaging & Containers companies is 1.56, based on 390 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current 3-Year ROIIC % of 16.04 is 928.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median 3-Year ROIIC % is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current 3-Year ROIIC % is 16.04, which is 24% below median its own 10-year median of 21.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.61, compared to a current price of ¥19.15 — trading 22.2% below its estimated fair value. The current 3-Year ROIIC % is 16.04, which is 24% below median its 10-year median of 21.11 and 928.2% above the Packaging & Containers industry median of 1.56. Shandong Pharmaceutical Glass Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current 3-Year ROIIC % is 16.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥19.15 is trading 22.2% below its estimated GF Value™ of ¥24.61.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
3-Year ROIIC %: 16.04 (24% below median its 10-year median of 21.11)
GF Value™: ¥24.61 vs. price of ¥19.15 (22.2% below fair value)
Industry Position: 928.2% above the Packaging & Containers median (#114 of 390)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
78GF Score
Get the complete analysis for SHSE:600529
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
